Overview

To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdos

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of TYNADOTE® in the treatment of acetaminophen overdose
Phase:
Phase 2
Details
Lead Sponsor:
Sinew Pharma Inc.
Collaborator:
Taipei Veterans General Hospital, Taiwan